Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Charles D. Kaplan

2 papers in the library · 211 citations · publishing 2002-2008

Papers

The ibogaine medical subculture.

Journal of Ethnopharmacology January 4, 2008 Kenneth Alper, Howard S. Lotsof, Charles D. Kaplan 184 citations

Ibogaine, a naturally occurring psychoactive alkaloid, is used within a global medical subculture to treat substance-related disorders, particularly opioid withdrawal. As of February 2006, an estimated 3,414 individuals had taken ibogaine—a fourfold increase from five years earlier—with 68% doing so for a substance-related disorder and 53% specifically for opioid withdrawal, the most common reason. The subculture lacks clinical and pharmaceutical standards, posing risks. Ethnographic analysis identified four types of ibogaine scenes: medical model, lay provider/treatment guide, activist/self-help, and religious/spiritual. The focus on opioid withdrawal distinguishes ibogaine from other psychedelics and aligns with experimental evidence of a significant pharmacologically mediated effect.

LSD therapy in Dutch psychiatry: changing socio-political settings and medical sets.

Med Hist April 1, 2002 Stephen Snelders, Charles D. Kaplan 27 citations

The word 'hallucinogens' is commonly used to classify LSD and similar drugs, but it is vague and sometimes confusing. A more clinically precise classification, proposed by Jean Delay in 1959, categorizes these substances as psychodysleptics because they disturb mental activity and distort a person's judgment of reality. This classification implicitly acknowledges that cultural definitions of reality shape the drug experience. Despite this precision, the authors choose to use the term 'hallucinogen' for literary reasons.